Friday, October 7, 2016

Cosopt


Cosopt is a brand name of dorzolamide/timolol ophthalmic, approved by the FDA in the following formulation(s):


COSOPT (dorzolamide hydrochloride; timolol maleate - solution/drops; ophthalmic)



  • Manufacturer: MERCK

    Approval date: April 7, 1998

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [RLD][AT]

Has a generic version of Cosopt been approved?


Yes. The following products are equivalent to Cosopt:


DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (dorzolamide hydrochloride; timolol maleate solution/drops; ophthalmic)



  • Manufacturer: ALCON RES

    Approval date: November 18, 2009

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [AT]


  • Manufacturer: APOTEX INC

    Approval date: October 28, 2008

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [AT]


  • Manufacturer: BAUSCH AND LOMB

    Approval date: July 14, 2009

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [AT]


  • Manufacturer: HI TECH PHARMA

    Approval date: October 28, 2008

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [AT]


  • Manufacturer: SANDOZ

    Approval date: November 6, 2008

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [AT]


  • Manufacturer: TEVA PARNTL

    Approval date: September 28, 2009

    Strength(s): EQ 2% BASE;EQ 0.5% BASE [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cosopt. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cosopt.

See also...

  • Cosopt Consumer Information (Drugs.com)
  • Cosopt Drops Consumer Information (Wolters Kluwer)
  • Cosopt Consumer Information (Cerner Multum)
  • Cosopt Advanced Consumer Information (Micromedex)
  • Cosopt Ocumeter Advanced Consumer Information (Micromedex)
  • Cosopt Ocumeter Plus Advanced Consumer Information (Micromedex)
  • Dorzolamide/Timolol Drops Consumer Information (Wolters Kluwer)
  • Dorzolamide and timolol ophthalmic Consumer Information (Cerner Multum)
  • Dorzolamide and timolol Ophthalmic Advanced Consumer Information (Micromedex)

Cortifoam


Cortifoam is a brand name of hydrocortisone, approved by the FDA in the following formulation(s):


CORTIFOAM (hydrocortisone acetate - aerosol, metered; rectal)



  • Manufacturer: MEDA PHARMS

    Approval date: February 10, 1982

    Strength(s): 10% [RLD]

Has a generic version of Cortifoam been approved?


No. There is currently no therapeutically equivalent version of Cortifoam available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cortifoam. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cortifoam.

See also...

  • Cortifoam foam, enema Consumer Information (Cerner Multum)
  • Hydrocortisone Consumer Information (Wolters Kluwer)
  • Hydrocortisone Enema Consumer Information (Wolters Kluwer)
  • Hydrocortisone Solution Consumer Information (Wolters Kluwer)
  • Hydrocortisone Consumer Information (Cerner Multum)
  • Hydrocortisone rectal foam, enema Consumer Information (Cerner Multum)
  • Hydrocortisone AHFS DI Monographs (ASHP)
  • Hydrocortisone Acetate AHFS DI Monographs (ASHP)
  • Hydrocortisone Sodium Phosphate AHFS DI Monographs (ASHP)
  • Hydrocortisone Sodium Succinate AHFS DI Monographs (ASHP)

Cortisporin Otic


Cortisporin Otic is a brand name of hydrocortisone/neomycin/polymyxin b otic, approved by the FDA in the following formulation(s):


CORTISPORIN (hydrocortisone; neomycin sulfate; polymyxin b sulfate - solution/drops; otic)



  • Manufacturer: MONARCH PHARMS

    Approved Prior to Jan 1, 1982

    Strength(s): 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML [RLD][AT]

Has a generic version of Cortisporin Otic been approved?


Yes. The following products are equivalent to Cortisporin Otic:


NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (hydrocortisone; neomycin sulfate; polymyxin b sulfate solution/drops; otic)



  • Manufacturer: ALCON

    Approval date: August 25, 1983

    Strength(s): 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML [AT]


  • Manufacturer: BAUSCH AND LOMB

    Approval date: December 29, 1995

    Strength(s): 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML [AT]


  • Manufacturer: LUITPOLD

    Approval date: October 31, 2005

    Strength(s): 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cortisporin Otic. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cortisporin Otic.

See also...

  • Cortisporin Solution Consumer Information (Wolters Kluwer)
  • Cortisporin Suspension Consumer Information (Wolters Kluwer)
  • Cortisporin Otic Consumer Information (Cerner Multum)
  • Cortisporin Otic Advanced Consumer Information (Micromedex)
  • Hydrocortisone/Neomycin/Polymyxin B Solution Consumer Information (Wolters Kluwer)
  • Hydrocortisone/Neomycin/Polymyxin B Suspension Consumer Information (Wolters Kluwer)
  • Hydrocortisone, neomycin, and polymyxin B otic Consumer Information (Cerner Multum)
  • Antibiotic Otic Advanced Consumer Information (Micromedex)
  • Neomycin, polymyxin b, and hydrocortisone Otic Advanced Consumer Information (Micromedex)

Cyklokapron


Cyklokapron is a brand name of tranexamic acid, approved by the FDA in the following formulation(s):


CYKLOKAPRON (tranexamic acid - injectable; injection)



  • Manufacturer: PHARMACIA AND UPJOHN

    Approval date: December 30, 1986

    Strength(s): 100MG/ML [RLD][AP]

Has a generic version of Cyklokapron been approved?


Yes. The following products are equivalent to Cyklokapron:


tranexamic acid injectable; injection



  • Manufacturer: MYLAN INSTITUTIONAL

    Approval date: November 3, 2011

    Strength(s): 100MG/ML [AP]


  • Manufacturer: PHARMAFORCE

    Approval date: August 10, 2011

    Strength(s): 100MG/ML [AP]


  • Manufacturer: VERSAPHARM INC

    Approval date: November 17, 2011

    Strength(s): 100MG/ML [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cyklokapron. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cyklokapron.

See also...

  • Cyklokapron Consumer Information (Wolters Kluwer)
  • Cyklokapron Tablet Consumer Information (Wolters Kluwer)
  • Cyklokapron Consumer Information (Cerner Multum)
  • Cyklokapron Advanced Consumer Information (Micromedex)
  • Tranexamic Acid Consumer Information (Wolters Kluwer)
  • Tranexamic Acid Tablet Consumer Information (Wolters Kluwer)
  • Tranexamic acid Consumer Information (Cerner Multum)
  • Tranexamic acid Advanced Consumer Information (Micromedex)
  • Tranexamic acid Intravenous Advanced Consumer Information (Micromedex)

Copegus


Copegus is a brand name of ribavirin, approved by the FDA in the following formulation(s):


COPEGUS (ribavirin - tablet; oral)



  • Manufacturer: ROCHE

    Approval date: December 3, 2002

    Strength(s): 200MG [AB]

Has a generic version of Copegus been approved?


A generic version of Copegus has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Copegus and have been approved by the FDA:


ribavirin tablet; oral



  • Manufacturer: AUROBINDO PHARMA

    Approval date: September 17, 2009

    Strength(s): 200MG [AB]


  • Manufacturer: SANDOZ

    Approval date: October 3, 2006

    Strength(s): 200MG [AB]


  • Manufacturer: TEVA

    Approval date: December 5, 2005

    Strength(s): 200MG [AB]


  • Manufacturer: THREE RIVERS PHARMS

    Approval date: December 5, 2005

    Strength(s): 200MG [AB]


  • Manufacturer: ZYDUS PHARMS USA

    Approval date: December 5, 2005

    Strength(s): 200MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Copegus. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Copegus.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • August 9, 2014 - NEW PATIENT POPULATION

See also...

  • Copegus Consumer Information (Wolters Kluwer)
  • Copegus Consumer Information (Cerner Multum)
  • Copegus Advanced Consumer Information (Micromedex)
  • Ribavirin Consumer Information (Wolters Kluwer)
  • Ribavirin Capsules Consumer Information (Wolters Kluwer)
  • Ribavirin Solution Consumer Information (Wolters Kluwer)
  • Ribavirin Consumer Information (Cerner Multum)
  • Ribasphere Ribapak Advanced Consumer Information (Micromedex)
  • Ribavirin Advanced Consumer Information (Micromedex)
  • Ribavirin Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
  • Ribavirin AHFS DI Monographs (ASHP)

Cordarone


Cordarone is a brand name of amiodarone, approved by the FDA in the following formulation(s):


CORDARONE (amiodarone hydrochloride - tablet; oral)



  • Manufacturer: WYETH PHARMS INC

    Approval date: December 24, 1985

    Strength(s): 200MG [RLD][AB]

Has a generic version of Cordarone been approved?


Yes. The following products are equivalent to Cordarone:


amiodarone hydrochloride tablet; oral



  • Manufacturer: APOTEX CORP

    Approval date: November 6, 2008

    Strength(s): 200MG [AB]


  • Manufacturer: AUROSAL PHARMS

    Approval date: April 8, 2005

    Strength(s): 200MG [AB]


  • Manufacturer: BARR

    Approval date: January 25, 2001

    Strength(s): 200MG [AB]


  • Manufacturer: MYLAN

    Approval date: February 24, 1999

    Strength(s): 200MG [AB]


  • Manufacturer: SANDOZ

    Approval date: December 23, 1998

    Strength(s): 200MG [AB]


  • Manufacturer: TARO

    Approval date: March 30, 2001

    Strength(s): 200MG [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: November 30, 1998

    Strength(s): 200MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: September 16, 2008

    Strength(s): 200MG [AB]

PACERONE (amiodarone hydrochloride tablet; oral)



  • Manufacturer: UPSHER SMITH

    Approval date: April 30, 1998

    Strength(s): 200MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cordarone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cordarone.

See also...

  • Cordarone Consumer Information (Wolters Kluwer)
  • Cordarone Consumer Information (Cerner Multum)
  • Cordarone Advanced Consumer Information (Micromedex)
  • Amiodarone Consumer Information (Drugs.com)
  • Amiodarone Consumer Information (Wolters Kluwer)
  • Amiodarone Solution Consumer Information (Wolters Kluwer)
  • Amiodarone Consumer Information (Cerner Multum)
  • Amiodarone injection Consumer Information (Cerner Multum)
  • Amiodarone Intravenous Advanced Consumer Information (Micromedex)
  • Amiodarone Intravenous, Oral Advanced Consumer Information (Micromedex)
  • Amiodarone Hydrochloride AHFS DI Monographs (ASHP)

Cozaar


Cozaar is a brand name of losartan, approved by the FDA in the following formulation(s):


COZAAR (losartan potassium - tablet; oral)



  • Manufacturer: MERCK

    Approval date: April 14, 1995

    Strength(s): 25MG [AB], 50MG [AB]


  • Manufacturer: MERCK

    Approval date: October 13, 1998

    Strength(s): 100MG [RLD][AB]

Has a generic version of Cozaar been approved?


Yes. The following products are equivalent to Cozaar:


losartan potassium tablet; oral



  • Manufacturer: ACTAVIS INC

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: ALEMBIC PHARMS LTD

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: APOTEX CORP

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: AUROBINDO PHARMA

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: LUPIN LTD

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: MYLAN

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: PRINSTON INC

    Approval date: June 6, 2011

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: ROXANE

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: SANDOZ

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: TEVA

    Approval date: April 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: TORRENT PHARMS

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: UPSHER SMITH

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cozaar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cozaar.

See also...

  • Cozaar Consumer Information (Drugs.com)
  • Cozaar Consumer Information (Wolters Kluwer)
  • Cozaar Consumer Information (Cerner Multum)
  • Cozaar Advanced Consumer Information (Micromedex)
  • Cozaar AHFS DI Monographs (ASHP)
  • Losartan Consumer Information (Wolters Kluwer)
  • Losartan Consumer Information (Cerner Multum)
  • Losartan Advanced Consumer Information (Micromedex)
  • Losartan Potassium AHFS DI Monographs (ASHP)